Spain’s National Markets and Competence Commission (CNMC) has launched an investigation into potential anti-competitive practices within the medical supply sector, specifically targeting the market for hospital serums and parenteral nutrition products. Between June 9 and June 12, 2026, antitrust officials conducted unannounced dawn raids at the headquarters of several companies operating within the industry.
The regulatory action stems from suspicions that competing firms may have orchestrated price-fixing agreements and systematically carved up customers and contract awards. These illicit practices reportedly targeted public and private hospital tenders, regional health departments, and centralized public procurement bodies handling regional healthcare demand. The CNMC emphasized that these on-site inspections are preliminary steps in the investigative process and do not prejudge the final outcome of the case or the legal guilt of the entities involved.
If the regulatory body uncovers definitive proof of a cartel, the targeted companies face severe legal and financial repercussions. Under Spain’s Competition Act, horizontal agreements between direct market competitors are classified as very serious infractions. Such violations can carry administrative fines of up to 10 percent of a non-compliant company’s total annual global turnover. Consequently, the CNMC prioritizes dismantling cartels due to the significant damage they inflict on public finances, consumer pricing, and overall market dynamics.
To aid in uncovering these covert market agreements, the CNMC actively promotes its Leniency Program. This framework incentivizes cartel members to come forward by offering full immunity from administrative fines to the first company providing decisive evidence of the illicit network. Firms that cooperate later in the process can still secure substantial fine reductions if their disclosures add significant qualitative value to the ongoing investigation. Crucially, companies applying for leniency are also shielded from statutory public procurement bans, which typically prohibit antitrust offenders from bidding on lucrative public sector contracts. Beyond corporate whistleblowing, the Spanish watchdog utilizes an anonymous public platform, the Anonymous Competition Informants System, allowing citizens to securely flag suspected price-fixing or market-sharing schemes.
